Reason for request
Reassessment of the Actual Benefit of all medicines indicated in hormone replacement therapy for menopause at the request of the Committee, pursuant to Article R-163-21 of the French Social Security Code
Clinical Benefit
| Substantial |
The actual benefit of the proprietary medicinal products CLIMENE in hormone replacement therapy (HRT) for symptoms of oestrogen deficiency in menopausal women remains substantial in patients for whom climacteric disorders are described as troublesome enough to impair their quality of life when these proprietary medicinal products are used as per the Committee's recommendations. |
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
4GUqHy6JsNk1kPrW
Listen
